Transplantation: A Report of Progress
Nobel Prizes in Medicine in the Field of Transplantation
A Transplant Recipient’s Experience
Introduction of the President of the Transplantation Society, Kathryn Wood
The Transplantation Society: Building on Success
The Transplantation Society Medawar Prize Ceremony 2006: Introduction
Introduction of Carl Gustav Groth
Medawar Prize Acceptance Speech
Introduction of Pekka Häyry
Medawar Prize Acceptance Speech
Introduction of Sir Peter John Morris
Medawar Prize Acceptance Speech
Elevated Soluble CD30 Correlates with Development of Bronchiolitis Obliterans Syndrome Following Lung Transplantation
Pretransplant Soluble CD30 Level Has Limited Effect on Acute Rejection, but Affects Graft Function in Living Donor Kidney Transplantation
Pretransplant Soluble CD30 Is a Better Predictor of Posttransplant Development of Donor-Specific Antibodies and Acute Vascular Rejection than Panel Reactive Antibodies
Clinicopathologic Monitoring of the Skin and Oral Mucosa of the First Human Face Allograft: Report on the First Eight Months
A Highly Efficient Living Donor Kidney Exchange Program for Both Blood Type and Crossmatch Incompatible Donor-Recipient Combinations
Alemtuzumab Induction and Tacrolimus Monotherapy in Pancreas Transplantation: One- and Two-Year Outcomes
Negative Impact of New-Onset Diabetes Mellitus on Patient and Graft Survival After Liver Transplantation: Long-Term Follow Up
Follow-up Study of the First Successful Living Donor Islet Transplantation
Long-Term Graft Outcome with Mycophenolate Mofetil and Azathioprine: A Paired Kidney Analysis
Successful Transplantation of Kidneys from Deceased Donors with Acute Renal Failure: Three-Year Results
Incidence of End-Stage Renal Disease Among Live Kidney Donors
Pancreas Transplantation Under Alemtuzumab (Campath-1H) and Tacrolimus: Correlation Between Low T-Cell Responses and Infection
Utilization of Extended Donor Criteria Liver Allograft: Is the Elevated Risk of Failure Independent of the Model for End-Stage Liver Disease Score of the Recipient?
Transplant Tourism: Outcomes of United States Residents Who Undergo Kidney Transplantation Overseas
The Older Living Kidney Donor: Part of the Solution to the Organ Shortage
The Use of Oral Glucose Tolerance Tests to Risk Stratify for New-Onset Diabetes After Transplantation: An Underdiagnosed Phenomenon
Risk Factors for Development of New-Onset Diabetes Mellitus After Kidney Transplantation
The MDR1/ABCB1 Gene, a High-Impact Risk Factor for Cardiac Transplant Rejection
Factors Affecting Graft Survival After Liver Transplantation from Donation After Cardiac Death Donors
Randomized Controlled Trial of FTY720 Versus MMF in De Novo Renal Transplantation
Pregnancy Outcomes in Solid Organ Transplant Recipients With Exposure to Mycophenolate Mofetil or Sirolimus
Predictors of Disease Recurrence Following Neoadjuvant Chemoradiotherapy and Liver Transplantation for Unresectable Perihilar Cholangiocarcinoma
Pediatric Liver and Kidney Transplantation With Allografts From DCD Donors: A Review of UNOS Data
Adoptive Transfer of TRAIL-Expressing Natural Killer Cells Prevents Recurrence of Hepatocellular Carcinoma After Partial Hepatectomy
Control of Allograft Rejection by Applying a Novel Nuclear Factor-κB Inhibitor, Dehydroxymethylepoxyquinomicin
Prevention of Renal Ischemic Injury by Silencing the Expression of Renal Caspase 3 and Caspase 8
Gene Transfer of Programmed Death Ligand-1.Ig Prolongs Cardiac Allograft Survival
Generation and Expansion of Human CD4+CD25+ Regulatory T Cells with Indirect Allospecificity: Potential Reagents to Promote Donor-Specific Transplantation Tolerance
The Impact of Transforming Growth Factor-β1 Gene Polymorphism on End-Stage Renal Failure After Heart Transplantation
Targeting Acute Allograft Rejection by Immunotherapy With Ex Vivo-Expanded Natural CD4+CD25+ Regulatory T Cells
Immature Syngeneic Dendritic Cells Potentiate Tolerance to Pancreatic Islet Allografts Depleted of Donor Dendritic Cells in Microgravity Culture Condition
Isolation of Regulatory T Cells in the Skin of a Human Hand-Allograft, Up to Six Years Posttransplantation
CD20+ Lymphocytes in Renal Allografts Are Associated with Poor Graft Survival in Pediatric Patients
Disparate Distribution of 16 Candidate Single Nucleotide Polymorphisms Among Racial and Ethnic Groups of Pediatric Heart Transplant Patients
Protection of Renal Ischemia Injury using Combination Gene Silencing of Complement 3 and Caspase 3 Genes
Increased Immunosuppression, Not Anticoagulation, Extends Cardiac Xenograft Survival
Conversion to Sirolimus in Renal Transplant Recipients with Skin Cancer